Amgen

Open: 276.84 Close: 273.17 Change: -3.67

What an AI found about Amgen Company Inc Stock after reading the whole Internet.

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, report, medicine, earnings, share, pioneer, new, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen reported fourth-quarter 2023 adjusted earnings of $4.71 per share, which beat the Zacks Consensus Estimate. Japan and Asia Pacific are the fastest growing region in Amgen.

Today's News

Amgen (amgn) down 6.5% since last earnings report: can it rebound? Amgen reported fourth-quarter 2023 adjusted earnings of $4.71 per share, which beat the Zacks Consensus Estimate. Amgen scientists are pioneering new approaches to understanding human biology and making innovative medicines to treat disease. Join leaders at Amgen and beyond for in-depth discussions of the latest science and discoveries. Amgen performed very effectively in 2022, reaching roughly 10 million patients around the world with our approved medicines. Amgen announced plans to invest more than $200 million to become carbon neutral by 2027, while also reducing our water use by 40% and our waste generated by 70% Amgen is committed to being a great place to work. Amgen is a pioneer in the science of using living cells to make biologic medicines. The market launches of Jubbonti and Wyost are uncertain due to ongoing patent litigation between Sandoz and Amgen. The forecasting team at Amgen plays a pivotal role as a strategic partner to Commercial leadership, offering data-backed insights crucial for driving commercial success. At Amgen our shared mission—to serve patients, drives all that we do. Senior Associate Production Scheduler is responsible for coordinating and managing the maintenance schedule in Amgen North Carolina. The FleX Batch facility will combine the latest in disposable technologies with traditional stainless-steel equipment. Amgen stock has gained 23% since 2021 primarily due to favorable change in revenues. Japan and Asia Pacific (JAPAC) are the fastest growing region in Amgen. Amgen announces positive 52-week data for Otezla in children with plaque psoriasis and successful late-breaking Phase 3 study results for palmoplantar pustulosis treatment. Senator Tommy Tuberville reported the sale of $15,001 - $50,000 of Amgen. Amgen presents new research on otezla® (apremilast) at aad 2024. Amgen Sees FY24 Revenue $32.4B-$33.8B Vs $32B Est; EPS $18.90-$20.30 Vs $20.00 Est. Be part of Amgens newest and most advanced drug substance manufacturing plant.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, report, medicine, earnings, share, pioneer, new, and the most common words in the summary are: amgen, stock, market, data, overview, news, science, . One of the sentences in the summary was: Japan and Asia Pacific are the fastest growing region in Amgen.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #data #overview #news #science.